
Chris Strouse
@strouse_chris
University of Iowa; Myeloma, Lymphoma and BMT
ID: 898851661
23-10-2012 01:17:13
596 Tweet
199 Followers
629 Following

Thank you Shebli Atrash for presenting our posters on RWE of talquetamab in RRMM and its use as a bridge to CART in #mmsm at #IMS24 Nausheen Ahmed MD Al-Ola A Abdallah MD (USMIRC) Chris Strouse Hamza Hashmi Reed Friend Prerna Mewawalla


Ahh.. it is almost time. Honoured to be presenting ASH #amyloidosis guidelines with Angela Dispenzieri Joselle Cook and Naresh Bumma at #ASH24


My friend, next-door (work) neighbor and colleague at UI Holden Comprehensive Cancer Center University of Iowa Chris Strouse presenting an oral soon at #ASH24 Making #Hematology #lymphoma team proud p-kit mutation


Frailty, number of lines of therapy and older age were the factors significantly related to CRS and ICANS after CART in R/R LBCL Chris Strouse #ASH24 #Hematology


Proud mentor of Mehndi Dandwani presenting our #MGRS data at #ASH24 as poster tonight. -> Hematological ≥VGPR to induction significantly affecting TTNT (HR 0.07, p<0.001) on univariate and multivariate. -> Novel therapies, including anti-CD38 had + outcomes, results not SS.


Expert moderation in action! Kudos to Joselle Cook Hira Shaikh for a great session on T-cell engager RWE in myeloma UI Holden Comprehensive Cancer Center #ASH24


Some sequencing pearls from our #ASH24 poster - talquetamab in #mmsm Best ORR 69%, 6 mo OS 75% Sequencing pearls ⬇️ORR if BCMA therapy was immediate LOT ⬆️ORR if >6 months gap after BCMA therapy (univariate analysis only) Chris Strouse Al-Ola A Abdallah MD (USMIRC) Hamza Hashmi Prerna Mewawalla



Proud of our UI Holden Comprehensive Cancer Center team’s multiple posters and talks at #Tandem25 Mehndi Dandwani p-kit mutation Chris Strouse


Our stellar fellow Mehndi Dandwani from UI Holden Comprehensive Cancer Center presenting proposal at #Tandem25 on HMA/ven +/- DLI in AML/MDS post-HSCT p-kit mutation Chris Strouse


Proud of our USMIRC News team for putting out so many posters at #Tandem2025 Highlighting this very relevant ❓ of options in BCMA exposed RRMM #mmsm by Jordan Snyder, PharmD, BCOP Al-Ola A Abdallah MD (USMIRC) Prerna Mewawalla Nausheen Ahmed MD Muhammad Umair Mushtaq (Abu Mikael) Hamza Hashmi James Davis, PharmD, BCOP


Our UI Holden Comprehensive Cancer Center #mmsm led BCMA CART manufacturing failure project presented at #Tandem25 . Time from Cytoxan affected successful manufacturing. Limited number of pts with TCE bsAb exposure. Brainchild of Chris Strouse Collab with James Davis, PharmD, BCOP USMIRC News


UI Holden Comprehensive Cancer Center representation at #Tandem25 Thanks for holding the floor down single-handedly Chris Strouse


Hira Shaikh Mehndi Dandwani UI Holden Comprehensive Cancer Center p-kit mutation Chris Strouse We would like to inform you that your post has been published on OncoDaily. Thank you for sharing. oncodaily.com/blog/244757





Thanks Oncology Data Advisor for choosing me and offering the avenue to express my journey. The humpback of fuel, guidance, and motivation comes from my mentors Dr Joseph McCollom DO Hira Shaikh Chris Strouse 🩺 ASCO PallOnc Community of Practice IMG Oncologists Hem-Onc Fellows Network UI Holden Comprehensive Cancer Center #Gratitude #Hemeonc

So proud and excited for our trainee Mehndi Dandwani at UI Holden Comprehensive Cancer Center University of Iowa Health Care being selected as fellow of the month Oncology Data Advisor and sharing her journey.